GSK-J1
-
- Applikation
- Inhibition (Inh)
- Verwendungszweck
- JMJ H3K27 Demethylase inhibitor (cell impermeable)
- Produktmerkmale
- Potent and selective inhibitor of jumonji H3K27 histone demethylases JMJD3 and UTX (IC50 = 60 nM, human JMJD3). This is the first known inhibitor selective for the H3K27me3-specific JMJ subfamily which binds to the active catalytic site of the enzyme. The COOH group confers cell impermeability and as such is useful as a standard in in vitro assays. A cell permeable ethyl ester analog is also available.
- Reinheit
- >98 %
- Chemical Name
- N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alanine
- Formel
- C22H23N5O2
- Permeabilität
- Not-permeable
- Löslichkeit
- Soluble in DMSO (up to 20 mg/ml).
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Powder
- Lagerung
- RT
-
- Hintergrund
- Epigenetics,Protein demethylase,Posttranslational modification,Chromatin
- Molekulargewicht
- 389.46
- CAS-Nummer
- 1373422-53-7
-